SEC Form 3 · accession 0000912282-26-001269
Co-Diagnostics, Inc. · CODX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Bohrer
Officer — EVP of Finance & Accounting
Period of report
Sep 2, 2026
Accepted (ET)
Sep 14, 2026 · 6:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001692415
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,657 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 2,722 unvested Restricted stock units (RSUs) awarded to the Reporting Person pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan comprised of 2,500 awarded on April 26, 2024 and 2,834 awarded on August 11, 2025, of which 1,667 and 945, respectively, previously vested. Vesting of April 26, 2024 award occurs in equal amounts every six months beginning November 23, 2024 and ending on May 23, 2027. Vesting of August 11, 2025 award occurs in equal amounts every six months beginning November 23, 2025 and ending on May 23, 2028.